The landscape of psychoactive substances is in a perpetual state of flux. Driven by industrial innovation and the insatiable human desire for altered states of consciousness, new psychoactive substances (NPS) are continuously emerging, posing significant challenges to public health and regulatory bodies. This comprehensive review aims to here explo